> Thus emphasizing the importance of controlled trials and regulatory bodies.
Funny, you give the results study that did not used controlled trials to justify emphasizing the importance of controlled trials. Even further, this study was not non-peer reviewed, or published (see https://edition.cnn.com/2020/04/21/health/hydroxychloroquine...)
All they did here was to review charts of people already treated and try to base their conclusions on only that. Even the study itself admits (https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v...):
However, hydroxychloroquine, with or without azithromycin, was more likely to be prescribed to patients with more severe disease, as assessed by baseline ventilatory status and metabolic and hematologic parameters. Thus, as expected, increased mortality was observed in patients treated with hydroxychloroquine, both with and without azithromycin.
There are a lot of people right now, including the MSM, dismissing of HCQ. I don't think that is warranted at this point. And I hate to see the media, who is heavily influenced by the pharmaceutical industry, who has a interest in preventing a cheap treatment from being widely used, downplaying HCQ and the public going along with it.